Asbestos-Related Diseases in a Population Near a Fibrous Cement Factory

Tarrés, Josep; Abós-Herràndiz, Rafael; Albertí, Constança; Martínez-Artés, Xavier; Rosell-Murphy, Magdalena; García-Allas, Isabel; Krier, Illona; Castro, Emilia; Cantarell, Gloria; Gallego, Miguel; Orriols, Ramon

doi:10.1016/S1579-2129(09)73485-8

Archivos de Bronconeumología

ISSN: 0300-2896

Archivos de Bronconeumologia is an international journal that publishes original studies whose content is based upon results of research initiatives dealing with several aspects of respiratory medicine including epidemiology, respiratory physiology, pathophysiology of respiratory diseases, clinical management, thoracic surgery, pediatric lung diseases, respiratory critical care, respiratory allergy and translational research. Other types of articles such as editorials, reviews, and different types of letters are also published in the journal. Additionally, the journal expresses the voice of the following scientific societies: the Spanish Respiratory Society of Pneumology and Thoracic Surgery (SEPAR; https://www.separ.es/), the Latin American Thoracic Society (ALAT; https://alatorax.org/), and the Iberian American Association of Thoracic Surgery (AIACT; http://www.aiatorax.com/).

It is a monthly journal in which all manuscripts are sent to peer-review and handled by the editor or an associate editor from the team and the final decision is made on the basis of the comments from the expert reviewers and the editors. The journal is published solely in English. All the published data is composed of novel manuscripts not previously published in any other journal and not being in consideration for publication in any other journal..

The journal is indexed at Science Citation Index Expanded, Medline/Pubmed, Embase and SCOPUS. Access to any published article is possible through the journal's web page as well as from Pubmed, ScienceDirect, and other international databases. Furthermore, the journal is also present in X, Facebook and Linkedin. Manuscripts can be submitted electronically using the following web site: https://www.editorialmanager.com/ARBR/.

Indexed in:

Current Contents/Clinical Medicine, JCR SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, SCOPUS, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

8.7

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.5

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.464

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.482

View more metrics

Open Access Option

Journal Information

Previous article | Next article

Vol. 45. Issue 9.

Pages 429-434 (September 2009)

More article options

Pages 429-434 (September 2009)

Original Article

DOI: 10.1016/S1579-2129(09)73485-8

Full text access

Asbestos-Related Diseases in a Population Near a Fibrous Cement Factory

Enfermedad por amianto en una población `próxima a una fábrica de fibrocemento

Visits

5031

Download PDF

Josep Tarrésa,

Corresponding author

7893jto@comb.es

Corresponding author.

, Rafael Abós-Herràndizb, Constança Albertíc, Xavier Martínez-Artésd, Magdalena Rosell-Murphye,f, Isabel García-Allasg, Illona Krierb, Emilia Castroh, Gloria Cantarelli, Miguel Gallegoi, Ramon Orriolsk,l

a EAP Canaletas, Cerdanyola del Vallès, Barcelona, Spain

b EAP Ripollet, Ripollet, Barcelona, Spain

c Institut Català d’Avaluacions Mèdiques, Barcelona, Spain

d EAP Serraparera, Cerdanyola del Vallès, Barcelona, Spain

e IDIAP Jordi Gol, Barcelona, Spain

f Servei d’Atenció Primària Cerdanyola-Ripollet, Cerdanyola del Vallès, Barcelona, Spain

g EAP Barberà, Barberà del Vallès, Barcelona, Spain

h EAP Badia, Badia del Vallès, Barcelona, Spain

i Servei de Medicina Interna, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain

k Servei de Pneumologia, Hospital Universitari Vall d’Hebron, Barcelona, Spain

l CIBER de Enfermedades Respiratorias (CibeRes), Barcelona, Spain

This item has received

5031 Visits

Article information

Statistics

Abstract

Background and Objective

The first fibrous cement factory in Spain was set up in Cerdanyola, Barcelona, in 1907 and was a source of pollution there until it was closed in 1997. The aim of this study was to determine the clinical and epidemiologic characteristics of the population with asbestos-related diseases who had worked in the factory and/or lived in the vicinity.

Material and Methods

We retrospectively collected information available on patients with asbestos-related diseases who at the time of diagnosis had resided in the area near the fibrous cement factory. Information was obtained from the medical records of the primary care centers of the 12 surrounding towns and the sole referral hospital in the area for cases diagnosed between January 1, 1970 and December 31, 2006.

Results

In the 559 patients diagnosed, 1107 cases of asbestos-related diseases were identified. Between 2000 and 2006, the average annual incidence was 9.5 cases per 100 000 inhabitants for the entire study area and 35.5 cases per 100 000 for the area nearest the factory. The prevalence of asbestos-related diseases as of December 31, 2006 was 91 cases per 100 000 inhabitants in the entire study area and 353.4 cases per 100 000 in the area nearest the factory. Of the 1107 asbestos-related disease cases identified, 86.5% were benign and 8.4% pleural mesothelioma.

Conclusions

The factory introduced an important area-wide risk factor for asbestos-related diseases for both workers and the nearby population. The number of cases detected annually showed an upward trend and the incidence of asbestos-related diseases was extremely high.

Keywords:

Asbestos

Incidence

Prevalence

Asbestosis

Pleural disease

Mesothelioma

Environmental disease

Resumen

Introducción

En 1907 se instaló en Cerdanyola (Barcelona) la primera fábrica de fibrocemento de España, que actuó como foco contaminante hasta su cierre en 1997. El objetivo del estudio ha sido conocer las características clinicoepidemiológicas de la población afectada por enfermedades relacionadas con el amianto (ERA) que había trabajado o/y vivía en el entorno de esta fábrica.

Material y métodos

Se trata de un estudio retrospectivo que reúne la información disponible de los pacientes afectados de ERA que residían en el momento del diagnóstico en la zona cercana a la factoría de fibrocemento. La información se obtuvo a partir de la documentación médica de los centros de atención primaria de las 12 poblaciones circundantes y del único hospital de referencia de la zona, para los casos diagnosticados entre el 1 de enero de 1970 y el 31 de diciembre de 2006.

Resultados

En los 559 pacientes diagnosticados se identificaron 1.107 casos de ERA. La incidencia anual media entre 2000 y 2006 fue de 9,5 pacientes por 100.000 habitantes para toda la zona, y de 35,5 para la más próxima a la fábrica. La prevalencia de pacientes con ERA a fecha de 31 de diciembre de 2006 fue de 91 por 100.000 personas en toda la zona y de 353,4 en la más próxima a la fábrica. De los 1.107 casos, el 86,5% correspondía a enfermedad benigna y el 8,4% a mesotelioma pleural.

Conclusiones

En la zona estudiada, la fábrica supuso un factor de riesgo importante de ERA para sus trabajadores y la población cercana. La detección de casos mostró una tendencia ascendente. La incidencia de ERA fue muy elevada.

Palabras clave:

Asbesto

Incidencia

Prevalencia

Asbestosis

Enfermedad pleural

Mesotelioma

Enfermedad ambiental

Full text is only aviable in PDF

References

[1.]

R. Orriols, R. Costa.

Enfermedades pulmonares de origen ocupacional.

Medicina interna. Barcelona, pp. 822-828

[2.]

American Thoracic Society.

Diagnosis and initial management of non-malignant diseases related to asbestos. American Thoracic Society Documents, 170 (2003), pp. 691-715

http://dx.doi.org/10.1164/rccm.200310-1436ST | Medline

[3.]

I.J. Selikoff, W.J. Nicholson, A.M. Langer.

Asbestos air pollution.

Arch Environ Health, 25 (1972), pp. 1-13

Medline

[4.]

J. Ferrer, C. Martínez.

El diagnóstico de las enfermedades respiratorias causadas por asbesto.

Arch Bronconeumol, 44 (2008), pp. 177-179

Medline

[5.]

A. Cárcova.

El amianto en España.

Ediciones GPS, (2000),

[6.]

J. Peto, J.T. Hodgson, F.E. Matthews, J.R. Jones.

Continuing increase in mesothelioma mortality in Britain.

Lancet, 345 (1995), pp. 535-539

Medline

[7.]

J. Peto, A. Decarli, C. La Vecchia, F. Levi, E. Negri.

The European mesothelioma epidemic.

Br J Can, 79 (1999), pp. 666-672

[8.]

EROL-SEPAR, grupo de trabajo.

Normativa sobre el asbesto y sus enfermedades pleuropulmonares.

Arch Bronconeumol, 41 (2005), pp. 153-168

Medline

[9.]

IDESCAT. Available from: www.idescat.cat/es/serviceweb/consultans_esp_jsp

[10.]

R. Kiviluoto.

Pleural calcification as roentgenologic sign of nonoccupational endemic anthophyllite-asbestosis.

Acta Radiol, 194 (1960), pp. 1-67

[11.]

J. Hromek.

The mass incidence of characteristic pleural changes in citizens of the western part of the former Jihlava region.

Rozhl V Tuberk, 22 (1962), pp. 405-515

[12.]

S.H. Constantopoulos, J.A. Goudevenos, N. Saratzis, A.E. Langer, I.J. Selikoff, H.M. Moutsopoulos.

Metsovo lung: pleural calcifications and restrictive lung function in northwestern Greece: environmental exposure to mineral fiber as etiology.

Environ Res, 38 (1985), pp. 319-331

Medline

[13.]

Y.I. Baris, M. Artvinli, A.A. Sahin, N. Bilir, F. Kalyoncu, P. Sebastien.

Non-occupational asbestos related chest disease in a small Anatolian village.

Br J Ind Med, 45 (1988), pp. 841-842

Medline

[14.]

F. Rey, C. Boutin, J.R. Viallat, J. Steinbauer, P. Alessandroni, P. Jutisz, et al.

Significance of biopersistence in relation to pathogenic effects in humans. Environmental asbestotic pleural plaques in northeast Corsica: correlations with airborne and pleural mineral analysis.

Environ Health Perspect, 102 (1994), pp. 251-252

Medline

[15.]

V. Raunio.

Occurrence of unusual pleural calcification in Finland: studies of atmospheric pollution caused by asbestos.

Ann Med Intern Fenn, 55 (1966), pp. 61

Medline

[16.]

J.C. Wagner, C.A. Sleggs, P. Marchand.

Diffuse pleural mesothelioma and asbestos exposure in North Western Cape Province.

Br J Ind Med, 17 (1960), pp. 250-271

[17.]

M.L. Newhouse, H. Thompson.

Mesothelioma of pleura and peritoneum following exposure to asbestos in the London area.

Br J Ind Med, 22 (1965), pp. 261-269

Medline

[18.]

J. Lieben, H. Pitawka.

Mesothelioma and asbestos exposure.

Arch Environ Health, 14 (1967), pp. 559-563

Medline

[19.]

C. Magnani, C. Ivaldi, N. Botta, B. Terracini.

Pleural malignant mesothelioma and environmental asbestos exposure in Casale Monferrato, Piedmont. Preliminary analysis of a case-control study.

Med Lab, 88 (1997), pp. 302-309

[20.]

J. Hansen, N.H. De Klerck, A.W. Musk, M.ST. Hobbs.

Environmental exposure to crocidolite and mesothelioma.

Am J Respir Crit Care Med, 157 (1998), pp. 69-75

http://dx.doi.org/10.1164/ajrccm.157.1.96-11086 | Medline

[21.]

M. Camus, J. Siemiatycki, B. Meek.

Non-occupational exposure to chrysotile asbestos and the risk of lung cancer.

N Engl J Med, 338 (1998), pp. 1565-1571

http://dx.doi.org/10.1056/NEJM199805283382201 | Medline

[22.]

B.W. Case.

Non-occupational exposure to chrysotile asbestos and the risk of lung cancer [letter].

N Engl J Med, 339 (1998), pp. 1001

Medline

[23.]

F. Segarra.

Riesgos de la inhalación de asbesto. Su importancia clínica.

Med Clin (Barc), 72 (1979), pp. 29-33

[24.]

G. Hillerdal.

Mesothelioma: cases associated with non-occupational and low dose exposures.

Occup Environ Med, 56 (1999), pp. 505-513

Medline

[25.]

A. Agudo.

Mesotelioma pleural y exposición ambiental al amianto [dissertation].

UAB, (2003),

[26.]

G. López-Abente, R. Ramis, M. Pollán, N. Aragonés, B. Pérez-Gómez, D. Gómez-Barroso, et al.

Atlas municipal de mortalidad por cáncer en España, 1989-1998.

Instituto de Salud Carlos III, (2006),

[27.]

C. Martínez, E. Monsó, A. Quero.

Enfermedades pleuropulmonares asociadas con la inhalación de asbestos. Una patología emergente.

Arch Bronconeumol, 40 (2004), pp. 166-177

Medline

[28.]

W.T. Hamilton, A.P. Round, D.J. Sharp, T.J. Peters.

High incidence of mesothelioma in an English city without heavy industrial use of asbestos.

J Pub Health, 26 (2004), pp. 77-78

[29.]

N. Kurumatani, S. Kumagai.

Mapping the risk of mesothelioma due to neighborhood asbestos exposure.

Am J Respir Crit Care Med, 178 (2008), pp. 624-629

http://dx.doi.org/10.1164/rccm.200801-063OC | Medline

[30.]

R.S. Fraser, N.L. Müller, N. Colman, P.D. Paré.

Asbestosis.

4.ª ed., pp. 2403-2431

[31.]

A. Agudo, C.A. González, M.J. Bleda, J. Ramírez, F. López, A. Calleja, et al.

Occupation and risk of malignant pleural mesothelioma: a case-control study in Spain.

Am J Ind Med, 37 (2000), pp. 159-168

Medline

[32.]

Grupo de Estudio del Mesotelioma en Barcelona (GEMEBA).

Mortalidad por mesotelioma pleural en la provincia de Barcelona.

Med Clin (Barc), 101 (1993), pp. 565-569

[33.]

K.H. Antman.

Current concepts: malignant mesothelioma.

N Engl J Med, 303 (1980), pp. 200-202

http://dx.doi.org/10.1056/NEJM198007243030407 | Medline

[34.]

G.Y.C. Lee, N.H. Klerk, D.W. Henderson, A.W. Musk.

Malignant mesothelioma.

Occupational disorders of the lung. Recognition, management and prevention,

[35.]

P. Boffeta.

Epidemiology of peritoneal mesothelioma: a review.

Ann Oncol, 18 (2007), pp. 985-990

http://dx.doi.org/10.1093/annonc/mdl345 | Medline

Tools

Indexed in:

Follow us:

Subscribe:

Subscribe to our newsletter